Wilson H Miller

8PUBLICATIONS
112CO-AUTHORS
Molecular targetsRespiratory diseasesHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 18, 2026
RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR.

Raúl E Flores-González, Christophe Goncalves, Noah Wirasinghe

|Dec 29, 2025
The CCL17-CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

Madelyn J Abraham, Cynthia Guilbert, Natascha Gagnon

|Mar 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

Reinhard Dummer, Shahneen Sandhu, Wilson H Miller

|Nov 22, 2024
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.

Cristiano Ferrario, John Mackey, Karen A Gelmon

|Sep 13, 2024
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.

Samuel E J Preston, Michael S Dahabieh, Raúl Ernesto Flores González

|Feb 01, 2023
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.

Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves

Pageof 2

Frequent Collaborators

5 joint publications

Sonia V Del Rincon

3 joint publications

Samuel Preston

3 joint publications

Christophe Gonçalves

2 joint publications

Theodore Papadopoulos